Trial record 1 of 1 for:    NCT01609283
Previous Study | Return to List | Next Study

A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Anthony J. Windebank, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01609283
First received: May 18, 2012
Last updated: December 29, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)